Concurrent targeting of HDAC and PI3K to overcome phenotypic heterogeneity of castration-resistant and neuroendocrine prostate cancers
Article in Cancer Research Communications (November 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms
Article in Cancer Chemotherapy and Pharmacology (November 2023)
Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer
Article in Molecular Pharmaceutics (October 2023)